blue triangle graphic

Our Stories

Smiling woman leader sitting in outdoor area at Alkermes facility.

Our mission and values come to life through our people, our progress and our impact. These stories highlight the unique qualities of who we are today, what we are working on and where we are going as an organization.

Keyword Search
No articles match your search criteria. Please try again.
Alkermes Employees Marching in Pride Parade
|Giving Back|Our People|Company Events|
Marking Women's Equality Day

Hear from three female senior leaders as they offer perspectives on our commitment to gender equality.

Craig Hopkinson, M.D.
|Leadership Perspectives|Science & Innovation|
Learning from Patients: Our Commitment to the Narcolepsy Community

Hear from Craig Hopkinson, M.D. as he reflects on the unmet needs of people living with narcolepsy.

Woman in Alkermes in Action shirt
|Giving Back|Our People|Company Events|
Alkermes in Action

This year, we’re celebrating 15 years of “Alkermes in Action,” our employee-led volunteer program that supports local non-profit organizations through hands-on activities.

Alkermes Employees Marching in Pride Parade
|Giving Back|Our People|Company Events|
Alkermes Celebrates Pride

Throughout June, Team Alkermes celebrated Pride Month with events hosted by Pride@Work, our ERG for LGBTQ+ employees and allies.

Pride@Work Employee Resource Group Logo
|Our People|Other|
Commitment to Equality

See what our valued co-leaders have to say about our ERG for LGBTQ+ employees and allies.

Headshot of Joyanna Wesche-Blake
|Our People|
HBA Rising Star 2023

We’re proud to recognize Swetha Krishnan, Senior Director of Quality, as our 2023 Healthcare Businesswomen’s Association (HBA) Rising Star – a testament to her leadership and commitment to excellence.

Steve Schiavo
|Leadership Perspectives|Our People|
Cultivating a Healthy Workplace

Hear from Steve Schiavo on Alkermes' commitment to being a recovery-friendly workplace.

Markus Haeberlein, Ph.D.
|Leadership Perspectives|Science & Innovation|
Showcasing Alkermes’ Commitment to the Sleep Community

Hear from Markus Haeberlein, Ph.D. where he discusses our commitment to researching potential treatment options for people living with sleep disorders.

Mosaic Employee Resource Group Logo
|Our People|Other|
Embracing Diversity at Alkermes

This Women’s History Month, we celebrate the accomplishments of the many women making a difference at Alkermes. Meet the co-leads of Mosaic, our ERG dedicated to multicultural diversity.

Portrait of Craig Hopkinson in cafeteria
|Leadership Perspectives|Science & Innovation|
Seeking to Fill Cancer Treatment Gaps

Hear from Dr. Craig Hopkinson in this PharmaVoice article where he discusses our commitment to developing novel potential therapies for people living with difficult-to-treat cancers.

Operation Salute Employee Resource Group Logo
|Our People|Other|
Honoring the Sacrifice

Hear from leaders of Operation Salute, our ERG dedicated to recognizing and supporting veterans and their family members.

Limitless Employee Resource Group Logo
|Our People|Other|
Building A Welcoming Workplace for All

Hear from leaders of Limitless, our ERG dedicated to empowering those whose lives are impacted by disability or illness.

Harris Poll logo on white background
|Leadership Perspectives|Progress for Patients|
Psychiatrist Perspectives

Alkermes worked with The Harris Poll to gather psychiatrists’ insights and perspectives on caring for people living with bipolar I disorder.

Headshot of Kanchan Relwani
|Our People|
HBA Luminary 2022

Congratulations to Kanchan Relwani, M.D., Head of Medical Affairs, for being recognized as our 2022 Healthcare Businesswomen’s Association Luminary – a testament to her role as a mentor and leader.

Portrait of employee standing in lab
|Science & Innovation|
Cancer Trials At-a-Glance

Learn more about our ongoing clinical development program for nemvaleukin alfa, our lead immuno-oncology candidate.

Portrait of employee standing masked in manufacturing lab
|Leadership Perspectives|Our People|
Our Pursuit of Progress

Alkermes' Head of Human Resources Steve Schiavo reflects on our employees' commitment during the COVID-19 pandemic.

Portrait of Craig Hopkinson in cafeteria
|Leadership Perspectives|Science & Innovation|
Unlocking IL-2's Potential

As the unmet medical need in oncology changes, Alkermes is using its R&D capabilities honed over 30 years of work on complex diseases to investigate a potential next breakthrough in cancer therapy.

Portrait of employee standing in front of Alkermes headquarters.
|Giving Back|Our People|Company Events|
Alkermes Gives Back

Alkermes employees seek to make a positive impact in their communities by taking part in Alkermes in Action, our employee-led volunteer program that represents our commitment to giving back to our loc

Harris Poll logo on white background
|Leadership Perspectives|Progress for Patients|
Pandemic Drinking Habits

Alkermes worked with The Harris Poll to conduct a survey exploring drinking patterns during the COVID-19 pandemic and people’s motivations to seek help.

Headshot of executive, Blair Jackson
|Leadership Perspectives|Science & Innovation|Progress for Patients|
Building for the Future

In a recent interview with Informa Connect's Xconomy, our Chief Operating Officer, Blair Jackson, discusses our ambitions and our evolving strategy in neuroscience and oncology.

Portrait of woman with mask and protective gear
|Science & Innovation|Company Events|
Alkermes at ASCO

We hosted a webcast in June 2021 with expert oncologists and ARTISTRY clinical program investigators to review data updates presented at the 2021 ASCO Annual Meeting.

Headshot of Joyanna Wesche-Blake
|Our People|
HBA Rising Star 2021

We’re proud to recognize Joyanna Wesche-Blake, Senior Director of IT, as our 2021 Healthcare Businesswomen’s Association (HBA) Rising Star – a testament to her leadership and commitment to excellence.

Headshot of CEO Richard Pops
|Science & Innovation|Company Events|
Investor R&D Day

We hosted a virtual Investor Day in March 2021 to discuss our research and development strategy and portfolio, including updates from our nemvaleukin alfa development program in immuno-oncology and ne

Headshot of Blair Jackson, blue background
|Leadership Perspectives|Science & Innovation|
In the News

In this “The Medicine Maker” article, our Chief Operating Officer, Blair Jackson, discusses how to determine corporate readiness when exploring a new therapeutic area and reflects on Alkermes' entry i